🔗 Visit the ClinicalTrials.gov page for NCT00925002
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. | J Neurol | 2013 | 1.54 |
| 2 | Effects of tafamidis on transthyretin stabilization and clinical outcomes in patients with non-Val30Met transthyretin amyloidosis. | J Cardiovasc Transl Res | 2013 | 1.09 |
| 3 | Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy. | Amyloid | 2016 | 0.81 |
| 4 | Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure. | Front Cardiovasc Med | 2015 | 0.79 |